Matches in Nanopublications for { ?s ?p "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 18 of
18
with 100 items per page.
- NP293644.RAVbB8g4QQIfvMK-1WgjfAfYmV7oMe71xuZN1SU_0cWUQ130_assertion description "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP293644.RAVbB8g4QQIfvMK-1WgjfAfYmV7oMe71xuZN1SU_0cWUQ130_provenance.
- assertion description "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1108792.RARdjLHWtSHLAywxjRdb4pfqz4Guez1ruE_BJIfs4D_z0130_assertion description "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108792.RARdjLHWtSHLAywxjRdb4pfqz4Guez1ruE_BJIfs4D_z0130_provenance.
- NP743807.RAl71Mj651vcPlDIbPcTr62nWzHOMTtS_T4wqdthh39-M130_assertion description "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP743807.RAl71Mj651vcPlDIbPcTr62nWzHOMTtS_T4wqdthh39-M130_provenance.
- NP1108794.RACriC0ebrhDDQvM2xWzcU6m_Nq2yDjJu4OaZZjbnqoSw130_assertion description "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108794.RACriC0ebrhDDQvM2xWzcU6m_Nq2yDjJu4OaZZjbnqoSw130_provenance.
- NP1108793.RAh43MDpMoKJR6eWxB_XhDgOuX6-fg6cQeoS90X93_Iic130_assertion description "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108793.RAh43MDpMoKJR6eWxB_XhDgOuX6-fg6cQeoS90X93_Iic130_provenance.
- NP497065.RAwDzOJV9yKFc_fCmGVvGPwG1DTyD7D08euITM4cY768U130_assertion description "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP497065.RAwDzOJV9yKFc_fCmGVvGPwG1DTyD7D08euITM4cY768U130_provenance.
- NP517006.RALjB-qRajWsbt77JYSaEeS6yQzXbWlNjhuj9mWa9oXfY130_assertion description "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP517006.RALjB-qRajWsbt77JYSaEeS6yQzXbWlNjhuj9mWa9oXfY130_provenance.
- NP589925.RA9FiSD3uGS42QRiYsBw6z9orCQT-PbZWW80IaPCI6sHI130_assertion description "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP589925.RA9FiSD3uGS42QRiYsBw6z9orCQT-PbZWW80IaPCI6sHI130_provenance.
- NP804810.RA_ocGJMEx0I9qhQgQqd0fTz8Hb2zKjBwUR59HVisq1wM130_assertion description "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804810.RA_ocGJMEx0I9qhQgQqd0fTz8Hb2zKjBwUR59HVisq1wM130_provenance.
- NP1108795.RAOktovcWIjZysoqGAfG_OMjL5x0W8XxmNU1iDlthJy9Y130_assertion description "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108795.RAOktovcWIjZysoqGAfG_OMjL5x0W8XxmNU1iDlthJy9Y130_provenance.
- NP1108797.RAK1aslfdtmzvCnExuq54zA-oPpuSd8OXO202JagypA9o130_assertion description "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108797.RAK1aslfdtmzvCnExuq54zA-oPpuSd8OXO202JagypA9o130_provenance.
- NP1108796.RA8Y6l0D5aYUpMMdXMPWB9Lubz89wk-4l7kQWyYjp88QM130_assertion description "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108796.RA8Y6l0D5aYUpMMdXMPWB9Lubz89wk-4l7kQWyYjp88QM130_provenance.